中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/25 | 3,730 | 3,739 | 3,676 | 3,698 | +6 | +0.2% | 2,598,500 |
| 2022/01/24 | 3,658 | 3,719 | 3,652 | 3,692 | +12 | +0.3% | 1,501,800 |
| 2022/01/21 | 3,674 | 3,697 | 3,637 | 3,680 | -9 | -0.2% | 2,126,900 |
| 2022/01/20 | 3,636 | 3,711 | 3,623 | 3,689 | +53 | +1.5% | 1,756,900 |
| 2022/01/19 | 3,710 | 3,723 | 3,616 | 3,636 | -97 | -2.6% | 2,047,200 |
| 2022/01/18 | 3,748 | 3,748 | 3,694 | 3,733 | -4 | -0.1% | 1,364,000 |
| 2022/01/17 | 3,783 | 3,805 | 3,726 | 3,737 | -13 | -0.3% | 1,160,000 |
| 2022/01/14 | 3,694 | 3,750 | 3,686 | 3,750 | +19 | +0.5% | 2,737,200 |
| 2022/01/13 | 3,810 | 3,816 | 3,727 | 3,731 | -94 | -2.5% | 1,828,500 |
| 2022/01/12 | 3,778 | 3,868 | 3,761 | 3,825 | +56 | +1.5% | 2,253,600 |
| 2022/01/11 | 3,738 | 3,769 | 3,686 | 3,769 | +44 | +1.2% | 2,106,800 |
| 2022/01/07 | 3,741 | 3,766 | 3,672 | 3,725 | -9 | -0.2% | 2,622,100 |
| 2022/01/06 | 3,797 | 3,824 | 3,734 | 3,734 | -61 | -1.6% | 2,164,600 |
| 2022/01/05 | 3,834 | 3,842 | 3,786 | 3,795 | -33 | -0.9% | 2,069,700 |
| 2022/01/04 | 3,770 | 3,839 | 3,714 | 3,828 | +93 | +2.5% | 1,959,600 |
| 2021/12/30 | 3,765 | 3,789 | 3,735 | 3,735 | -37 | -1% | 1,555,700 |
| 2021/12/29 | 3,764 | 3,801 | 3,742 | 3,772 | -25 | -0.7% | 1,185,700 |
| 2021/12/28 | 3,737 | 3,808 | 3,736 | 3,797 | +50 | +1.3% | 1,583,200 |
| 2021/12/27 | 3,740 | 3,772 | 3,728 | 3,747 | -22 | -0.6% | 1,339,300 |
| 2021/12/24 | 3,750 | 3,775 | 3,738 | 3,769 | +19 | +0.5% | 1,094,400 |
| 2021/12/23 | 3,728 | 3,750 | 3,705 | 3,750 | +8 | +0.2% | 1,148,900 |
| 2021/12/22 | 3,703 | 3,748 | 3,702 | 3,742 | +42 | +1.1% | 1,759,400 |
| 2021/12/21 | 3,679 | 3,712 | 3,650 | 3,700 | +83 | +2.3% | 2,216,500 |
| 2021/12/20 | 3,612 | 3,676 | 3,591 | 3,617 | +5 | +0.1% | 2,576,500 |
| 2021/12/17 | 3,694 | 3,720 | 3,612 | 3,612 | -198 | -5.2% | 4,377,800 |
| 2021/12/16 | 3,836 | 3,836 | 3,777 | 3,810 | +66 | +1.8% | 2,728,600 |
| 2021/12/15 | 3,770 | 3,777 | 3,727 | 3,744 | -33 | -0.9% | 2,278,700 |
| 2021/12/14 | 3,838 | 3,838 | 3,744 | 3,777 | +30 | +0.8% | 2,706,500 |
| 2021/12/13 | 3,788 | 3,796 | 3,731 | 3,747 | +47 | +1.3% | 1,662,200 |
| 2021/12/10 | 3,761 | 3,771 | 3,693 | 3,700 | -90 | -2.4% | 3,209,400 |
| 2021/12/09 | 3,838 | 3,848 | 3,787 | 3,790 | -84 | -2.2% | 2,349,500 |
| 2021/12/08 | 3,788 | 3,904 | 3,769 | 3,874 | +246 | +6.8% | 3,830,100 |
| 2021/12/07 | 3,598 | 3,658 | 3,539 | 3,628 | +100 | +2.8% | 3,146,500 |
| 2021/12/06 | 3,625 | 3,645 | 3,490 | 3,528 | -148 | -4% | 2,851,700 |
| 2021/12/03 | 3,662 | 3,697 | 3,630 | 3,676 | +11 | +0.3% | 2,313,000 |
| 2021/12/02 | 3,646 | 3,688 | 3,630 | 3,665 | +31 | +0.9% | 2,596,100 |
| 2021/12/01 | 3,663 | 3,699 | 3,610 | 3,634 | -46 | -1.3% | 2,551,900 |
| 2021/11/30 | 3,833 | 3,851 | 3,666 | 3,680 | -120 | -3.2% | 5,112,600 |
| 2021/11/29 | 3,900 | 3,922 | 3,784 | 3,800 | -125 | -3.2% | 3,060,500 |
| 2021/11/26 | 4,020 | 4,043 | 3,906 | 3,925 | -133 | -3.3% | 2,635,700 |
| 2021/11/25 | 4,051 | 4,107 | 4,044 | 4,058 | -20 | -0.5% | 1,255,900 |
| 2021/11/24 | 4,133 | 4,155 | 4,063 | 4,078 | -90 | -2.2% | 1,506,200 |
| 2021/11/22 | 4,098 | 4,183 | 4,081 | 4,168 | +56 | +1.4% | 1,384,900 |
| 2021/11/19 | 4,133 | 4,143 | 4,073 | 4,112 | -21 | -0.5% | 1,455,400 |
| 2021/11/18 | 4,121 | 4,188 | 4,104 | 4,133 | -18 | -0.4% | 1,303,400 |
| 2021/11/17 | 4,148 | 4,159 | 4,103 | 4,151 | -14 | -0.3% | 1,376,500 |
| 2021/11/16 | 4,155 | 4,220 | 4,150 | 4,165 | -39 | -0.9% | 1,211,700 |
| 2021/11/15 | 4,115 | 4,217 | 4,114 | 4,204 | +86 | +2.1% | 1,556,800 |
| 2021/11/12 | 4,150 | 4,159 | 4,102 | 4,118 | +6 | +0.1% | 2,200,600 |
| 2021/11/11 | 4,060 | 4,133 | 4,058 | 4,112 | +36 | +0.9% | 1,644,900 |
801～
850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
